Posted by Tina Su on February 26, 2003 at 21:05:31:
OFFER: [TW] hepatitis diagnostic reagent, HIV diagnostic reagent
The goals of R & D in GBC are development of new biotechnologies and
improvement of the qualities of raw materials used in current EIA
diagnostic kits. Our research scientists devoted to the development of
several new areas of technologies including :
Human monoclonal antibodies for potential therupeutic treatments in
cancer and infectious disease.
Phagemid screening system for potential drug screening.
Protein designs for potential components used in vitro diagnostic kits
by genetic engineering.
Subtype-specific in vitro diagnostic kits.
Design and self supply of new raw materials For EIA diagnostic kits
including viral antigens and antibodies.
Company: General Biologicals Corporation
Contact: Tina Su (Sales Manager)
Address: No.6, Innovation 1st Rd., SBIP,
Hsinchu, Taiwan, R.O.C.
Post a Followup